Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Burcon NutraScience reports quarterly EPS of -0.29 CAD and revenue jump to 0.8 million CAD
Burcon NutraScience reported quarterly earnings per share of -0.29 CAD for the quarter ended March 31, 2026, compared with -0.23 CAD a year earlier. Quarterly revenue rose to 0.8 million CAD, an increase of 1,975% versus the same quarter last year. For the full year the company reported a loss per share of -1.120 CAD and annual revenue of 2.26 million CAD (prior year: 0.38 million CAD). » More on finanzen.net
Burcon NutraScience to release quarterly results on 24 June 2026 with positive EPS and revenue forecasts
Burcon NutraScience will announce on 24 June 2026 the results for the quarter ended 31 March 2026. One analyst expects earnings per share of -0.100 CAD versus -0.230 CAD in the prior year and revenue of 1.4 million CAD, which would represent an increase of 3,400 percent compared with the same quarter a year earlier. For the fiscal year just ended, a loss per share of -0.940 CAD and annual revenue of 2.8 million CAD are forecast. » More on finanzen.net
Burcon NutraScience appoints Chris Bunio to the board of directors
Burcon NutraScience has appointed Chris Bunio, co‑founder and CEO of TheoryMesh with long-standing Microsoft experience, to its board of directors. At the same time, Jeanne McCaherty and Richard Nazur Jr. are leaving the board. The company, which develops plant-based protein ingredients such as Peazzaz, FavaPro and Puratein, is operating in a challenging financial environment: the stock is down 28% year-to-date, trading at $17.91 with a market capitalization of around $0.56 million; however, there have recently been signs of renewed investor interest. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFundamentals
| Metric | Value |
|---|---|
Market capitalization | €0 |
| Dividends | No |
Beta | 2.39 |
P/E ratio | -0.89 |
PEG ratio | 0.01 |
P/B ratio | -1.42 |
P/S ratio | 3.57 |
Company profile
Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. Its products include Peazazz, a pea protein for dairy alternative products, such as protein bars and crisps, weight management and meal replacement products, and vegetarian and vegan foods, as well as dry blended and ready-to-drink beverages; and Peazac, a pea protein for plant-based meat alternative products, ready-to-mix powders and beverages, dairy alternatives, nutrition bars, and other applications. The company also provides Puratein, a canola protein isolate for use in meat alternatives, such as burgers, sausages, and nutrition bars; Supertein, a canola protein that is a light colored powder for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows and ready-to-mix beverages, whipped toppings, and plant based bars; and Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods. In addition, it offers Nutratein-PS, a blend of Peazazz pea protein and Supertein canola protein for use in dairy alternative beverages; Nutratein-TZ, a blend of Peazac pea protein and Puratein canola protein for use in plant-based burgers or sausages; and CLARISOY, a soy protein for use in sports nutrition beverages, dairy alternative yogurts and cheeses, powdered beverage mixes, coffee creamers, and other foods and nutritional products. Further, the company provides MeritPro, a nutritional protein blend, including allergen-free, gluten-free, non-dairy, non-GMO, and vegan. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. Burcon NutraScience Corporation was incorporated in 1998 and is headquartered in Vancouver, Canada.
| Name | Burcon Nutrascience Co. |
| CEO | Johann Franz Tergesen |
| Headquarters | Vancouver,
bc Canada |
| Website | |
| Sector | Health Care |
| Industry | Biotechnology |
| IPO | 05/25/2021 |
| Employees | 26 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | BRCNF |
Toronto Stock Exchange | BU.TO |
NASDAQ | BRCN |
Frankfurt | BNE.F |
Düsseldorf | BNE.DU |
München | BNE.MU |